The multi-center clinical trial has enrolled 258 healthy participants between the ages of 18 and 50 years, making this study the largest Phase I study conducted to date by Vaxxas with its HD-MAP ...

We think it can be appropriate to present phase 2 trial participation as offering a small prospect of benefit,” researchers wrote. About 16% of patients enrolled in phase 2 cancer trials receive a ...

Clinical trials are research studies testing the safety and efficacy of emerging medical therapies. They consist of up to 5 phases that start with exploratory evaluations and end with a post ...

New results from the phase 1 clinical trial, now published in the journal Nature, show that the therapeutic cancer vaccine activated tumor-specific immune cells that persisted in the body up to nearly ...

The proportion increases when considering off-label use but drops when considering drugs with substantial clinical benefit. HealthDay News — One in 6 patients in phase 2 clinical cancer trials ...